BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27237108)

  • 1. Tryptophan hydroxylase type 2 variants modulate severity and outcome of addictive behaviors in Parkinson's disease.
    Cilia R; Benfante R; Asselta R; Marabini L; Cereda E; Siri C; Pezzoli G; Goldwurm S; Fornasari D
    Parkinsonism Relat Disord; 2016 Aug; 29():96-103. PubMed ID: 27237108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction among childhood trauma and functional polymorphisms in the serotonin pathway moderate the risk of depressive disorders.
    Van der Auwera S; Janowitz D; Schulz A; Homuth G; Nauck M; Völzke H; Rose M; Meyer zu Schwabedissen H; Freyberger HJ; Grabe HJ
    Eur Arch Psychiatry Clin Neurosci; 2014 Nov; 264 Suppl 1():S45-54. PubMed ID: 25214390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease.
    Kraemmer J; Smith K; Weintraub D; Guillemot V; Nalls MA; Cormier-Dequaire F; Moszer I; Brice A; Singleton AB; Corvol JC
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1106-11. PubMed ID: 27076492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants.
    Castro-Martínez XH; García-Ruiz PJ; Martínez-García C; Martínez-Castrillo JC; Vela L; Mata M; Martínez-Torres I; Feliz-Feliz C; Palau F; Hoenicka J
    Parkinsonism Relat Disord; 2018 Apr; 49():100-103. PubMed ID: 29361389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of tryptophan hydroxylase 2 (TPH2) in schizophrenia and in the response to antipsychotics.
    Schuhmacher A; Becker T; Rujescu D; Quednow BB; Lennertz L; Wagner M; Benninghoff J; Rietschel M; Häfner H; Franke P; Wölwer W; Gaebel W; Maier W; Mössner R
    J Psychiatr Res; 2012 Aug; 46(8):1073-80. PubMed ID: 22655589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TPH2 -703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression.
    Yoon HK; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):403-9. PubMed ID: 19162119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims.
    Zill P; Büttner A; Eisenmenger W; Möller HJ; Bondy B; Ackenheil M
    Biol Psychiatry; 2004 Oct; 56(8):581-6. PubMed ID: 15476687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of dopamine pharmacotherapy and addiction-like behaviors in Parkinson's disease.
    Napier TC; Kirby A; Persons AL
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Aug; 102():109942. PubMed ID: 32272129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine dysregulation syndrome in Parkinson's disease: from clinical and neuropsychological characterisation to management and long-term outcome.
    Cilia R; Siri C; Canesi M; Zecchinelli AL; De Gaspari D; Natuzzi F; Tesei S; Meucci N; Mariani CB; Sacilotto G; Zini M; Ruffmann C; Pezzoli G
    J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):311-8. PubMed ID: 23591553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Imaging of Addictive Behavior in Idiopathic Parkinson's Disease.
    Ghadery C; Valli M; Mihaescu A; Strafella R; Navalpotro I; Kim J; Strafella AP
    Int Rev Neurobiol; 2018; 141():365-404. PubMed ID: 30314604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression.
    Kloiber S; Kohli MA; Brueckl T; Ripke S; Ising M; Uhr M; Menke A; Unschuld PG; Horstmann S; Salyakina D; Muller-Myhsok B; Binder EB; Holsboer F; Lucae S
    Mol Psychiatry; 2010 Jul; 15(7):736-47. PubMed ID: 19125159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of regulatory TPH2 polymorphisms with higher reduction in depressive symptoms in children and adolescents treated with fluoxetine.
    Gassó P; Rodríguez N; Boloc D; Blázquez A; Torres T; Gortat A; Plana MT; Lafuente A; Mas S; Arnaiz JA; Lázaro L
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul; 77():236-240. PubMed ID: 28456685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of variations in the tryptophan hydroxylase-2 (TPH2) gene in cocaine dependence.
    Dahl JP; Cubells JF; Ray R; Weller AE; Lohoff FW; Ferraro TN; Oslin DW; Kampman KM; Dackis C; Tang Y; Gelernter J; Kranzler HR; O'Brien CP; Berrettini WH
    Addict Biol; 2006 Mar; 11(1):76-83. PubMed ID: 16759340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression.
    Zill P; Baghai TC; Zwanzger P; Schüle C; Eser D; Rupprecht R; Möller HJ; Bondy B; Ackenheil M
    Mol Psychiatry; 2004 Nov; 9(11):1030-6. PubMed ID: 15124006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease.
    Cormier-Dequaire F; Bekadar S; Anheim M; Lebbah S; Pelissolo A; Krack P; Lacomblez L; Lhommée E; Castrioto A; Azulay JP; Defebvre L; Kreisler A; Durif F; Marques-Raquel A; Brefel-Courbon C; Grabli D; Roze E; Llorca PM; Ory-Magne F; Benatru I; Ansquer S; Maltête D; Tir M; Krystkowiak P; Tranchant C; Lagha-Boukbiza O; Lebrun-Vignes B; Mangone G; Vidailhet M; Charbonnier-Beaupel F; Rascol O; Lesage S; Brice A; Tezenas du Montcel S; Corvol JC;
    Mov Disord; 2018 Dec; 33(12):1878-1886. PubMed ID: 30444952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between gene polymorphism and depression in Parkinson's disease: A case-control study.
    Zheng J; Yang X; Zhao Q; Tian S; Huang H; Chen Y; Xu Y
    J Neurol Sci; 2017 Apr; 375():231-234. PubMed ID: 28320136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic TPH2 variants and the susceptibility for migraine: association of a TPH2 haplotype with migraine without aura.
    Jung A; Huge A; Kuhlenbäumer G; Kempt S; Seehafer T; Evers S; Berger K; Marziniak M
    J Neural Transm (Vienna); 2010 Nov; 117(11):1253-60. PubMed ID: 20740293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TPH2 gene variants and anxiety during alcohol detoxification outcome.
    Serretti A; Liappas I; Mandelli L; Albani D; Forloni G; Malitas P; Piperi C; Politis A; Tzavellas EO; Papadopoulou-Daifoti Z; Zisaki A; Prato F; Batelli S; Polito L; De Ronchi D; Kalofoutis A
    Psychiatry Res; 2009 May; 167(1-2):106-14. PubMed ID: 19361870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hopelessness, a potential endophenotpye for suicidal behavior, is influenced by TPH2 gene variants.
    Lazary J; Viczena V; Dome P; Chase D; Juhasz G; Bagdy G
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):155-60. PubMed ID: 21946031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptophan hydroxylase-2 gene variation influences personality traits and disorders related to emotional dysregulation.
    Gutknecht L; Jacob C; Strobel A; Kriegebaum C; Müller J; Zeng Y; Markert C; Escher A; Wendland J; Reif A; Mössner R; Gross C; Brocke B; Lesch KP
    Int J Neuropsychopharmacol; 2007 Jun; 10(3):309-20. PubMed ID: 17176492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.